Latest Breaking News On - Novartis india limited - Page 1 : comparemela.com

Ranjit Shahani, pharma veteran and former VC, MD of Novartis India, passes away

Ranjit Shahani, pharma veteran and former VC, MD of Novartis India, passes away
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesUttar pradeshRanjit shahaniAsia pacificNovartis indiaImperial chemical industriesOrganisation of pharmaceuticals producers indiaJb chemicals pharmaceuticalsJamnalal bajaj institute of managementRoche productsFormer vice chairmanManaging directorGeneral managerLatin americanRoche products limited

Who was Ranjit Shahani: A titan in India s pharmaceutical, business landscape

Ranjit Shahani, was an influential figure in Indian pharma,and former President of OPPI. With a mechanical engineering degree from IIT Kanpur and an MBA from JBIMS Bombay, Shahani held notable positions at ICI and Roche Products before joining Novartis in 1997.

United statesUnited kingdomAurobindo pharmaAsia pacificRanjit shahaniRoche productsNovartis india ltdNovartis indiaOrganisation of pharmaceutical producers indiaImperial chemical industriesHikal ltdAmbuja cements ltdSwiss indian chamberGeneral managerLatin americaRoche products limited

Former Vice Chairman of Novartis India Ranjit Shahani passes away

Ranjit Shahani, former Vice Chairman and Managing Director of Novartis India and Chairman of JB Pharmaceuticals, has passed away.

United statesUttar pradeshAsia pacificRanjit shahaniShahani linkedinIndian institute of technologyNovartis india ltdSwiss indian chamberRoche productsAmbuja cements ltdImperial chemical industriesIndia research centreAdvisory councilHikal ltdNovartis indiaOrganisation of pharmaceutical producers india

Fierce Pharma Asia—Daiichi s €1B expansion; Astellas $800M cell-therapy bet; Novartis India s strategic review

Fierce Pharma Asia—Daiichi s €1B expansion; Astellas $800M cell-therapy bet; Novartis India s strategic review
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Daiichi sankyoNovartis healthcare privateNovartis indiaNovartis india limitedNovartis healthcare private limitedMedicines codeEverest medicines

Pharma MNCs: Why are pharma MNCs reducing India footprint? - A Deep Dive Analysis | India News

India News: Discover the reasons why pharma MNCs like Novartis, AstraZeneca, Pfizer, Sanofi, and GSK are reducing their footprint in India. Learn about the challenges they face, the transition from manufacturing to licensing and marketing agreements, and the impact on the Indian pharma industry.

United kingdomNovartis indiaNovartis india limitedNdia newsNdia news todayOday newsGoogle newsReaking newsPharma mncsLicensing agreementsIntellectual property regimeIndia footprint